Developability of Biopharmaceuticals

-

By accounting for developability in candidate selection, drug developers have the potential to greatly minimize costly attrition and reduce development time significantly. However, this rapidly expanding area is not without its challenges, and key issues surrounding the early implementation of molecular assessments and rational engineering approaches need to be addressed.

Developability of Biopharmaceuticals has been designed to support drug developers in reducing the cost, risk and time of development. Our agenda focuses on the opportunities such as monitoring protein thermostability to ensure optimal conditions for bioprocess and exploring new high throughput screening methods to improve confidence in candidate selection.

Location:
Revere Hotel
USA


Organizer: Hanson Wade

4 Dec 2012

UPCOMING FEATURED EVENTS 1 2 Next 
PepTalk: The Protein Science Week19 Jan 2015 Read
SLAS20157 Feb 2015 Read
Electronic Data in Clinical Trials24 Feb 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
Biotherapeutics Analytical Summit9 Mar 2015 Read
Extracellular Biomarkers Summit16 Mar 2015 Read
Targeting Mitochondrial Dysfunction & Toxicity19 Mar 2015 Read
AACR (American Association for Cancer Research)18 Apr 2015 Read


ALL UPCOMING EVENTS